Papa Joseph C
- SEC CIK
- 0001242215
No open-market purchases or sales filed in the past year.
Current role at each company
- CADL Candel Therapeutics, Inc.Directoras of Jul 1, 2026
- MIST Milestone Pharmaceuticals Inc.Directoras of Jun 12, 2026
- EBS Emergent BioSolutions Inc.President and CEOas of May 1, 2026
- RXDX Prometheus Biosciences, Inc.Directoras of Jun 16, 2023
- BHC Bausch Health Companies Inc.Directoras of May 12, 2022
Show 1 more company
- BLCO Bausch & Lomb CorpCEO & Chairmanas of May 9, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Papa Joseph C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EBS Emergent BioSolutions Inc.
President and CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 (view filing) | May 13 | 2 days | Papa Joseph CPresident and CEO | PPurchase | +60.0K | $5.83 | +$349.8K | +21.2%342.5K after |
CADL Candel Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2022 (view filing) | Dec 8-9 | 4 days | Papa Joseph CDirector | PPurchase | +38.0K | $1.92 | +$73.1K | New position38.0K after | 2 lots |